Alexander disease: The story behind an eponym

J Hist Neurosci. 2023 Oct-Dec;32(4):399-422. doi: 10.1080/0964704X.2023.2190354. Epub 2023 Mar 31.

Abstract

In 1949, William Stewart Alexander (1919-2013), a young pathologist from New Zealand working in London, reported the neuropathological findings in a 15-month-old boy who had developed normally until the age of seven months, but thereafter had progressive enlargement of his head and severe developmental delay. The most striking neuropathological abnormality was the presence of numerous Rosenthal fibers in the brain. The distribution of these fibers suggested to Alexander that the primary pathological change involved astrocytes. In the next 15 years, five similar patients were reported, and in 1964 Friede recognized these cases reflected a single disease process and coined the eponym "Alexander's disease" to describe the disorder. In the 1960s, electron microscopy confirmed that Rosenthal fibers were localized to astrocytes. In 2001, it was shown that Alexander disease is caused by mutations in the gene encoding glial fibrillary acidic protein, the major intermediate filament protein in astrocytes. Although the clinical, imaging, and pathological manifestations of Alexander disease are now well known, few people are familiar with Alexander's career. Although he did not make a further contribution to the literature on Alexander disease, his observations and accurate interpretation of the neuropathology have justified the continued use of the eponym "Alexander disease."

Keywords: Alexander disease; Rosenthal fibers; astrocyte; glial fibrillary acidic protein; neuropathology.

MeSH terms

  • Alexander Disease* / genetics
  • Alexander Disease* / metabolism
  • Alexander Disease* / pathology
  • Astrocytes / metabolism
  • Astrocytes / pathology
  • Brain / pathology
  • Eponyms
  • Humans
  • Infant
  • Male
  • Mutation